Trends in the use of neoadjuvant chemotherapy for advanced ovarian cancer in the United States

Abstract Objective Neoadjuvant chemotherapy and interval debulking surgery for the treatment of advanced ovarian cancer has remained controversial, despite the publication of two randomized trials comparing this modality with primary cytoreductive surgery. This study describes temporal trends in the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gynecologic oncology 2016-11, Vol.143 (2), p.236-240
Hauptverfasser:	Melamed, Alexander, MD, MPH, Hinchcliff, Emily M., MD, Clemmer, Joel T., MA, Bregar, Amy J., MD, MS, Uppal, Shitanshu, MD, Bostock, Ian, MD, Schorge, John O., MD, del Carmen, Marcela G., MD, MPH, Rauh-Hain, J. Alejandro, MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Advanced ovarian cancer Aged Aged, 80 and over Chemotherapy, Adjuvant Female Hematology, Oncology and Palliative Medicine Humans Middle Aged Neoadjuvant chemotherapy Neoadjuvant Therapy Neoplasm Staging Obstetrics and Gynecology Ovarian Neoplasms - diagnosis Ovarian Neoplasms - drug therapy Ovarian Neoplasms - therapy Temporal trends
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!